G

Genedrive PLC
LSE:GDR

Watchlist Manager
Genedrive PLC
LSE:GDR
Watchlist
Price: 2.375 GBX 5.56% Market Closed
Market Cap: 12.9m GBX
Have any thoughts about
Genedrive PLC?
Write Note

Intrinsic Value

GDR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one GDR stock under the Base Case scenario is 0.41 GBX. Compared to the current market price of 2.375 GBX, Genedrive PLC is Overvalued by 83%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GDR Intrinsic Value
0.41 GBX
Overvaluation 83%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation Backtest
Genedrive PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GDR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GDR?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Life Sciences Tools & Services Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Genedrive PLC

Provide an overview of the primary business activities
of Genedrive PLC.

What unique competitive advantages
does Genedrive PLC hold over its rivals?

What risks and challenges
does Genedrive PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genedrive PLC.

Provide P/S
for Genedrive PLC.

Provide P/E
for Genedrive PLC.

Provide P/OCF
for Genedrive PLC.

Provide P/FCFE
for Genedrive PLC.

Provide P/B
for Genedrive PLC.

Provide EV/S
for Genedrive PLC.

Provide EV/GP
for Genedrive PLC.

Provide EV/EBITDA
for Genedrive PLC.

Provide EV/EBIT
for Genedrive PLC.

Provide EV/OCF
for Genedrive PLC.

Provide EV/FCFF
for Genedrive PLC.

Provide EV/IC
for Genedrive PLC.

Show me price targets
for Genedrive PLC made by professional analysts.

What are the Revenue projections
for Genedrive PLC?

How accurate were the past Revenue estimates
for Genedrive PLC?

What are the Net Income projections
for Genedrive PLC?

How accurate were the past Net Income estimates
for Genedrive PLC?

What are the EPS projections
for Genedrive PLC?

How accurate were the past EPS estimates
for Genedrive PLC?

What are the EBIT projections
for Genedrive PLC?

How accurate were the past EBIT estimates
for Genedrive PLC?

Compare the revenue forecasts
for Genedrive PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genedrive PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genedrive PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genedrive PLC compared to its peers.

Compare the P/E ratios
of Genedrive PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Genedrive PLC with its peers.

Analyze the financial leverage
of Genedrive PLC compared to its main competitors.

Show all profitability ratios
for Genedrive PLC.

Provide ROE
for Genedrive PLC.

Provide ROA
for Genedrive PLC.

Provide ROIC
for Genedrive PLC.

Provide ROCE
for Genedrive PLC.

Provide Gross Margin
for Genedrive PLC.

Provide Operating Margin
for Genedrive PLC.

Provide Net Margin
for Genedrive PLC.

Provide FCF Margin
for Genedrive PLC.

Show all solvency ratios
for Genedrive PLC.

Provide D/E Ratio
for Genedrive PLC.

Provide D/A Ratio
for Genedrive PLC.

Provide Interest Coverage Ratio
for Genedrive PLC.

Provide Altman Z-Score Ratio
for Genedrive PLC.

Provide Quick Ratio
for Genedrive PLC.

Provide Current Ratio
for Genedrive PLC.

Provide Cash Ratio
for Genedrive PLC.

What is the historical Revenue growth
over the last 5 years for Genedrive PLC?

What is the historical Net Income growth
over the last 5 years for Genedrive PLC?

What is the current Free Cash Flow
of Genedrive PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genedrive PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genedrive PLC

Current Assets 3.2m
Cash & Short-Term Investments 1.2m
Receivables 1.4m
Other Current Assets 539k
Non-Current Assets 279k
PP&E 279k
Current Liabilities 1.9m
Accounts Payable 788k
Other Current Liabilities 1.1m
Efficiency

Earnings Waterfall
Genedrive PLC

Revenue
272k GBP
Operating Expenses
-5.2m GBP
Operating Income
-4.9m GBP
Other Expenses
-95k GBP
Net Income
-5m GBP

Free Cash Flow Analysis
Genedrive PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GDR Profitability Score
Profitability Due Diligence

Genedrive PLC's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 1-Year Revenue Growth
ROE is Increasing
ROIC is Increasing
35/100
Profitability
Score

Genedrive PLC's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

GDR Solvency Score
Solvency Due Diligence

Genedrive PLC's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
62/100
Solvency
Score

Genedrive PLC's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GDR Price Targets Summary
Genedrive PLC

There are no price targets for GDR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GDR?

Click here to dive deeper.

Dividends

Genedrive PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for GDR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Genedrive PLC

Country

United Kingdom

Industry

Life Sciences Tools & Services

Market Cap

12.9m GBP

Dividend Yield

0%

Description

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.

Contact

MANCHESTER
48 Grafton Street
+441619890245.0
www.genedriveplc.com

IPO

2007-04-04

Employees

46

Officers

CFO, Secretary & Director
Mr. Russell John Shaw
CEO, Chief Scientific Officer & Executive Director
Dr. Gino Miele Ph.D.

See Also

Discover More
What is the Intrinsic Value of one GDR stock?

The intrinsic value of one GDR stock under the Base Case scenario is 0.41 GBX.

Is GDR stock undervalued or overvalued?

Compared to the current market price of 2.375 GBX, Genedrive PLC is Overvalued by 83%.

Back to Top